CandiZYME (2013-10-20)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Natural health products
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 2526300 | - Recalling Firm
- Renew Life Canada
- 8-1273 North Service Road
- Oakville
- L6H 1A7
- Ontario
- CANADA
- Marketing Authorization Holder
- Renew Life Canada
- 8-1273 North Service Road
- Oakville
- L6H 1A7
- Ontario
- CANADA
| CandiZYME | Capsules | NPN 80036437 | 1,3-beta-D-xylan xylanohydrolase 37.5 mg 15000.0 FCC HCU |
Recalled Products
CandiZYME
The product may contain the drug ingredient chloramphenicol.
National retail distribution.